These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21770858)

  • 21. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y; Hua Q; Lei H; Li P
    J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
    J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent axonal degeneration in an Alzheimer mouse model.
    Wirths O; Weis J; Kayed R; Saido TC; Bayer TA
    Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diosgenin is an exogenous activator of 1,25D₃-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice.
    Tohda C; Urano T; Umezaki M; Nemere I; Kuboyama T
    Sci Rep; 2012; 2():535. PubMed ID: 22837815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins.
    Tohda C; Matsumoto N; Zou K; Meselhy MR; Komatsu K
    Neuropsychopharmacology; 2004 May; 29(5):860-8. PubMed ID: 15010693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2.
    Gutiérrez IL; González-Prieto M; Caso JR; García-Bueno B; Leza JC; Madrigal JLM
    Mol Neurobiol; 2019 Dec; 56(12):8628-8642. PubMed ID: 31297718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
    J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.
    Yamada M; Hayashida M; Zhao Q; Shibahara N; Tanaka K; Miyata T; Matsumoto K
    J Ethnopharmacol; 2011 Jun; 135(3):737-46. PubMed ID: 21513784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vortioxetine administration attenuates cognitive and synaptic deficits in 5×FAD mice.
    Jiang LX; Huang GD; Su F; Wang H; Zhang C; Yu X
    Psychopharmacology (Berl); 2020 Apr; 237(4):1233-1243. PubMed ID: 31953648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.
    Onozuka H; Nakajima A; Matsuzaki K; Shin RW; Ogino K; Saigusa D; Tetsu N; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
    J Pharmacol Exp Ther; 2008 Sep; 326(3):739-44. PubMed ID: 18544674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of normobaric hyperoxia on behavioral deficits and neuropathology in Alzheimer's disease mouse model.
    Gao B; Long Z; Zhao L; He G
    J Alzheimers Dis; 2011; 27(2):317-26. PubMed ID: 21799251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kamikihito reduces β-amyloid
    Nagamatsu T; Kubota K; Watanabe T; Katsurabayashi S; Iwasaki K
    J Nat Med; 2024 Jan; 78(1):246-254. PubMed ID: 38010476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trigonelline recovers memory function in Alzheimer's disease model mice: evidence of brain penetration and target molecule.
    Farid MM; Yang X; Kuboyama T; Tohda C
    Sci Rep; 2020 Oct; 10(1):16424. PubMed ID: 33009465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
    De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC
    Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
    Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
    Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amyloid-β plaque proximity on the axon initial segment of pyramidal cells.
    León-Espinosa G; DeFelipe J; Muñoz A
    J Alzheimers Dis; 2012; 29(4):841-52. PubMed ID: 22337828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model.
    Cai M; Lee JH; Yang EJ
    J Neuroinflammation; 2019 Dec; 16(1):264. PubMed ID: 31836020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.